Hong Kong-based chat management platform imBee has raised $5 million in a Series A round, while Tecon Pharmaceutical, a subsidiary of the Shenzhen-listed Tecon Biology, has secured $139 million to expand its manufacturing capabilities.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
